Nemluvio Side Effects
Generic name: nemolizumab
Medically reviewed by Drugs.com. Last updated on Oct 10, 2024.
Note: This document provides detailed information about Nemluvio.
Applies to nemolizumab: parenteral prefilled pen Side Effects associated with nemolizumab. Some dosage forms listed on this page may not apply specifically to the brand name Nemluvio.
Applies to nemolizumab: parenteral prefilled pen.
Side effects include:
Atopic dermatitis: Most common adverse reactions (≥1%) were headache (including migraine), arthralgia, urticaria, myalgia.
Prurigo nodularis: Most common adverse reactions (≥1%) were headache, dermatitis atopic, eczema, eczema nummular.
For healthcare professionals
Applies to nemolizumab: subcutaneous powder for injection.
Dermatologic adverse events
- Common (1% to 10%): Dermatitis atopic, eczema, eczema nummular[Ref]
Hypersensitivity
- Frequency not reported: Hypersensitivity reactions[Ref]
Nervous system
- Common (1% to 10%): Headache[Ref]
See also:
References
1. (2024) "Product Information. Nemluvio (nemolizumab)." Galderma Laboratories Inc
More about Nemluvio (nemolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Nemluvio side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
